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Prions have been documented in extra-neuronal and extra-lymphatic tissues of humans and various ruminants affected by
Transmissible Spongiform Encephalopathy (TSE). The presence of prion infectivity detected in cervid and ovine blood tempted
us to reason that kidney, the organ filtrating blood derived proteins, may accumulate disease associated PrP
Sc. We collected
and screened kidneys of experimentally, naturally scrapie-affected and control sheep for renal deposition of PrP
Sc from
distinct, geographically separated flocks. By performing Western blot, PET blot analysis and immunohistochemistry we found
intraepithelial (cortex, medulla and papilla) and occasional interstitial (papilla) deposition of PrP
Sc in kidneys of scrapie-
affected sheep. Interestingly, glomerula lacked detectable signals indicative of PrP
Sc. PrP
Sc was also detected in kidneys of
subclinical sheep, but to significantly lower degree. Depending on the stage of the disease the incidence of PrP
Sc in kidney
varied from approximately 27% (subclinical) to 73.6% (clinical) in naturally scrapie-affected sheep. Kidneys from flocks without
scrapie outbreak were devoid of PrP
Sc. Here we demonstrate unexpectedly frequent deposition of high levels of PrP
Sc in ovine
kidneys of various flocks. Renal deposition of PrP
Sc is likely to be a pre-requisite enabling prionuria, a possible co-factor of
horizontal prion-transmission in sheep.
Citation: Ligios C, Cancedda GM, Margalith I, Santucciu C, Madau L, et al (2007) Intraepithelial and Interstitial Deposition of Pathological Prion Protein
in Kidneys of Scrapie-Affected Sheep. PLoS ONE 2(9): e859. doi:10.1371/journal.pone.0000859
INTRODUCTION
Scrapie, a fatal, transmissible spongiform encephalopathy (TSE) of
sheep and goat caused by prions, has been intensively studied for
more than a century [1]. It is broadly accepted that scrapie is
caused by prions, as are bovine spongiform encephalopathy (BSE),
Creutzfeldt-Jakob disease (CJD) of humans, including those of
sporadic, familial, iatrogenic and variant etiology, chronic wasting
disease (CWD) of deer, elk, and moose, and a variety of rarer
diseases of several other animal species. Prions are thought to
mainly consist of PrP
Sc, a misfolded and aggregated form of the
cellular prion protein (PrP
C) [2] and are used as a surrogate
marker for prion affected animals. Many fundamental aspects of
peripheral and central scrapie pathogenesis however are yet not
understood. A particular important question relates to those
factors permitting horizontal transmission of scrapie within sheep
flocks. Although the main target of prion-induced pathology is the
central nervous system (CNS), PrP
Sc can be readily demonstrated
in the lymphoreticular system (LRS) in many TSEs [3,4–5,6].
Moreover, PrP
Sc and/or prion infectivity were demonstrated to
accumulate at extraneural and extralymphatic sites, including
skeletal muscle, mammary gland, placenta and salivary gland in
sheep [7,8–9,10] as well as skeletal muscle [11,12–13,14] and
blood in man [15,16] and mice [17] or in saliva [10] and skeletal
muscles of deer [18]. Yet it is difficult to envisage how tissues that
are not exposed to the outer environment might contribute to
prion spread among sheep in a flock. Blood was long thought to
harbor very little-if any-prion infectivity, yet this assumption was
shaken by the efficient blood-borne sheep-to-sheep transmission of
scrapie [19], cervid [20] and BSE prions [21] as well as blood-
borne transmission incidents of variant CJD (vCJD) between
humans [15,16,22]. In mice, sheep and deer, chronic lymphocytic
inflammation can shift the distribution pattern of PrP
Sc or prion
infectivity to non-lymphoid organs, being they in the kidney of
mouse and deer [23,24], liver and pancreas of mouse [25], and
mammary gland of sheep [8]. Extraneural deposition of PrP
Sc
appears to become prominent in Creutzfeldt-Jakob disease when
PrP
C is abundantly available as a substrate, as demonstrated in
muscle with inclusion body myositis containing macrophages and
lymphocytes [13]. In many instances ectopic prion infectivity and/
or PrP
Sc was detected in pre-clinically prion-infected individuals
[23,25]. Besides enabling high renal prion loads, chronic
lymphocytic inflammation in kidney combined with pathological
alterations of the renal filtration apparatus was demonstrated to
induce prionuria in both preclinical and terminally scrapie-sick
mice [25]. The latter studies yielded the first evidence that
excretory organs, when affected by chronic inflammation, can
release prion infectivity into the environment. Alternatively,
considering that in physiological conditions prions or PrP
Sc have
been detected in blood of sheep and hamsters affected by scrapie
[21,17], prionuria could occur in the absence of renal immuno-
pathological changes [26]. This last data together with the recent
finding of deposition of PrP
Sc in the salivary glands of sheep with
scrapie [10] accentuate that prionuria may occur, hence
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validate this hypothesis, as a first step, we investigated kidneys of
experimentally and naturally scrapie-affected sheep derived from
distinct scrapie outbreaks.
RESULTS
Conventional and Sodium phosphotungstate
(NaPTA)-Western blot analysis
Spongiosis, astrogliosis and PrP
Sc deposition were found by means
of histopathological and immunohistochemical analysis in the
brain of all analyzed 72 clinically scrapie-affected Sarda sheep. In
addition, presence of PrP
Sc was confirmed by conventional and
NaPTA-Western blot analysis in the brain, and by immunohis-
tochemistry in the lymphoid tissues (e.g. spleen and palatine
tonsils). Identical analysis was performed in sheep lacking clinical
signs (sheep from Sardinian, scrapie-free flocks n=30; sheep from
scrapie-affected flocks from Abruzzo and Sardinia n=67) and did
not lead to the detection of PrP
Sc in brains and tonsils.
Histopathological examination demonstrated the presence of
focal interstitial inflammatory changes, moderate tubular de-
generation as well as interstitial fibrosis in some kidneys from the
72 clinically scrapie-affected sheep. However, the damage was
moderate in all cases and no overall differences were found when
animals belonging to the different groups were compared to the
controls (Table 1).
The analysis of PrP
Sc deposition in kidneys from the 72
clinically scrapie-affected Sarda sheep indicated 53 (73.6%) or 52
(71.2%) positive cases by using Western blot analysis after NaPTA
precipitation or conventional Western blot analysis, respectively.
The scrapie sheep positive for PrP
Sc in kidney were evenly
distributed through all flocks investigated in Sardinia. In contrast,
all 79 kidney homogenates derived from control Sarda sheep (49
from scrapie affected sheep and 30 from scrapie-free sheep) were
negative for PrP
Sc as analyzed by NaPTA precipitation and
conventional Western blot analysis. Results resemble at least 2 or 3
independent Western blot analyses after NaPTA precipitation with
independent regions of the sheep kidneys.
Three out of the 11 (27%) kidneys from asymptomatic sheep
collected from the Sardinian scrapie-affected flock were PrP
Sc
positive by means of conventional Western blot analysis (Table 1
and 2). Nevertheless, the immuno-histochemical profile and the
histopathological features of the obex from these sheep were
indicative of clinical stage.
All the 3 scrapie clinical sheep from Abruzzo were positive for
PrP
Sc in brain. In addition, NaPTA-Western blot analysis of the
renal homogenates of these 3 sheep demonstrated the presence of
PrP
Sc in 2 of them. Oppositely, renal homogenates from all
healthy sheep (n=18), coming from the same flock, were negative
for PrP
Sc.
These data demonstrate that the incidence of renal PrP
Sc
deposition in sheep rises with the clinical stage of disease and
underline that also subclinical sheep can accumulate PrP
Sc in
kidney.
Finally, we set out to investigate whether the same phenomenon
of renal PrP
Sc deposition occurs in experimentally infected scrapie
terminal Sarda sheep. Again, in contrast to controls that were
negative for PrP
Sc in kidney, we detected PrP
Sc in 2 out of 9
clinically scrapie sick sheep by conventional Western-blotting and
6 out of 9 by NaPTA-Western blot.
In order to investigate if both cortical and medullary regions
(cortex and medulla) of the kidney display PrP
Sc we separately
performed NaPTA and conventional Western blot analysis in the
respective areas of randomly selected kidneys from Sardinia and
Abruzzo sheep. Even though we witnessed apparent variation in
the amount of cortical and medullary PrP
Sc, a positive signal was
found in both regions of all positive kidneys investigated
(Figure 1A). Variations in the intensity of the kidney-derived
PrP
Sc signal were observed. We hypothesized that the Western-
blotting signals become more intense in kidneys from sheep in
relative later stage of scrapie. Further, we screened all renal
homogenates by NaPTA-Western blot analysis (Figure 1B).
Table 1. Number (N), age, PrP genotype and clinical status of the sheep included in the study.
..................................................................................................................................................
Scrapie-affected sheep
Region N flocks N sheep Genotypes (N) Infection Age (years) Clinical signs
Sardinia 14 72 ARQ/ARQ (63) ARQ/AHQ (9) Natural 2 to 5 Yes
Sardinia 1 9 ARQ/ARQ Experimental 2 Yes
Abruzzo 1 3 ARQ/ARQ Natural 1.5 to 4 Yes
Sardinia 1 11 ARQ/ARQ Natural 2 to 5 No
Scrapie negative sheep
Sardinia 2 30 ARQ/ARQ (10) No 2 to 5 No
ARQ/ARQ (14)
ARR/ARR (3)
AHQ/AHQ (1)
ARQ/ARH (1)
Sardinia 1 49* ARQ/ARQ No 2 to 5 No
Abruzzo 1 18* ARR/ARR (3) No 1.5 to 7 No
ARR/ARQ (8)
ARQ/ARQ (6)
ARQ/VRQ (1)
Sheep are grouped as scrapie-affected sheep or negative control. The number (N) of the flocks from which the sheep were selected is also indicated.
*Sheep from scrapie-affected flock
doi:10.1371/journal.pone.0000859.t001
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Immunohistochemical analysis
In order to better define the localization and to verify the presence
of PrP
Sc in kidneys with different methods, we performed PET blot
analysis on paraffin sections of natural scrapie-sick and control
sheep. As indicated PrP
Sc is clearly detectable in the tubular
structures of the renal cortex and medulla (Figure 2B and C),
including the papillae (Figure 2D). In the medulla the rate of
immunostained tubular structures (collecting ducts) was higher
than in the cortex, where immuno-positive signals were restricted
to a few convoluted tubules. All negative animals were devoid of
PK resistant PrP
Sc in the kidney.
Immunohistochemical and immunofluorescence analysis of
consecutive paraffin sections from randomly selected kidneys of
Sardinian naturally scrapie affected sheep (n=33) demonstrated
that 23 out of the 33 kidneys showed deposits of PrP
Sc positive for
F99 antibody or for 2G11 (Figure 3A and B). Immunohistochem-
istry results were not always congruent with results gained from
NaPTA and conventional Western blot analysis, though the rate of
PrP
Sc positivity obtained by immunohistochemistry was compa-
rable to Western blot analysis (69.6% versus 73.6% and 71.2%).
Moreover, all 23 kidneys accumulated PrP
Sc in both the cortex
and the medulla, including the collecting ducts and the papillae, as
demonstrated by PET blot and immunohistochemistry analysis
(Figures 2 and 3). Kidney paraffin sections from control sheep
remained negative for staining by 2G11 and F99 (Figures 2 and 3).
The intensity of PrP
Sc staining varied among the different kidneys
and regions (cortex, medulla, papillae). Notably, the immunohis-
tochemical patterns were different depending on the antibody
used. Our analysis demonstrated granular PrP
Sc deposits with the
2G11 antibody exclusively within the epithelial tubular cells of the
convoluted tubules and the collecting ducts (Figure 3A). On the
contrary, immunostaining with F99 showed presence of PrP
Sc
staining on the surface of tubular cells of convoluted tubules
(cortex) and in the collecting ducts (medulla and papillae)
(Figure 3A). Moreover, with the same antibody in two cases PrP
Sc
staining was demonstrated in the intertubular spaces of the renal
papillae displaying a granular deposition, mostly around the basal
membrane of the tubular structures (Figure 3A). Surprisingly, in
these two cases, serial renal sections of the same area identified
PrP
Sc granular deposits only within the tubular cells of the
collecting ducts when probed with the 2G11 antibody. With both
antibodies in the medulla the rate of immunostained tubular
structures was higher than in the cortex, where immuno-positive
signals were restricted to a few convoluted tubules.
Quantification of renal PrP
C and PrP
Sc in scrapie-sick
and control sheep
Furthermore we determined the relative amount of renal PrP
Sc in
scrapie-sick sheep compared to brain derived PrP
Sc. Serial dilution
experiments of PK digested brain homogenates spiked into kidneys
from healthy sheep were performed, thereby generating a standard
curve for the amount of PrP
Sc/mg of brain tissue from various
brain samples (Figure 4). These results were compared to a selected
Table 2. Number (N) of examined Sarda breed sheep, with or without clinical signs, displaying PrP
Sc in the kidney, indicated as
percentage (%).
..................................................................................................................................................
Clinically affected sheep
Number of examined sheep
Number of positive sheep for conventional Western blotting
PrP
Sc in the kidney (%)* Infection
72 52 (71.2%) Natural
Number of clinically healthy sheep
11 3 (27%) Natural
The results are only referred to conventional Western blot examinations.
doi:10.1371/journal.pone.0000859.t002
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Figure 1. Western Blotting PrP
Sc deposition in scrapie-affected Sarda
sheep. (A) Detection of PrP
Sc by conventional Western blot in the
cortical and medullar part of kidneys. Brain and kidney homogenates
were treated with (+) or without (2) proteinase K (PK), amounts of
kidney and brain represented in each line are 1mg and 1g respectively.
S.b.=brain derived from a naturally scrapie-sick sheep; h.b.=brain
derived from a scrapie-free sheep control; h.k.=kidney derived from
a scrapie-free sheep control, s.k.=kidney derived from a naturally
scrapie-sick sheep. kD=kilo Dalton, M=medulla, C=cortex. (B) De-
tection of PrP
Sc by NaPTA Western blot in kidney homogenate derived
from different Sarda sheep. Substantial individual variation of the
Western blotting signal was observed among the sheep examined.
Spike control=brain homogenate derived from a scrapie–sick sheep
spiked into negative control kidney homogenate. h.b.=brain derived
from a scrapie-free sheep control. 2000–4000 mg of renal homogenate
were used as a starting material to perform NaPTA precipitation.
doi:10.1371/journal.pone.0000859.g001
PrPSc in Kidneys of Sheep
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the identical blot. After densiometric analysis, the relative amount
of PrP
Sc found in mgs of kidney homogenate was quantified and
blotted as percentage of PrP
Sc positive signal intensity found in mgs
of brain homogenates (Figure 4). The relative amount of PrP
Sc
found in kidney ranged from 5–10 fold to 100–500 fold lower than
in brain. Even though 100–500 fold less PrP
Sc was detected in
kidney when compared to brain, PrP
Sc was still detectable by
NaPTA and conventional Western blot analysis.
Genetic analysis
Sequencing of the complete PrP gene (PRNP) of clinically scrapie-
affected 16 sheep (8 of which harbouring PrP
Sc in the kidney)
confirmed the ARQ/ARQ genotype for all of them and did not
demonstrate the existence of additional polymorphisms. All
remaining genotypes of sheep were determined at codon 136,
154 and 171 (Table 1).
DISCUSSION
Our study involved a high number of animals, providing good
evidence that PrP
Sc can be found to high degree in the medullary
and the cortical regions of kidneys derived from ARQ/ARQ
scrapie-sick sheep. Moreover, we can demonstrate that the
incidence of renal PrP
Sc deposition increases with the stage of
disease.
Presence of PrP
Sc in kidney was detected in renal glomerula of
cats [27] and cheetah [28] affected by feline spongiform
encepaholpathy by the means of immunohiostochemical analysis.
However, both findings are observations without Western blot or
Histoblot and PET blot analysis, which are essential to prove the
effective presence of PrP
Sc, a surrogate marker of prion infectivity.
In addition, Herzog and colleagues [29] described PrP
Sc
accumulation in kidney of primates experimentally inoculated
with BSE by using an ELISA-based assay. However, also this
technique did not allow to localize PrP
Sc nor to characterize renal
PrP
Sc biochemically. In contrast to the described PrP
Sc deposition
pattern in cats or cheetah, we do not find PrP
Sc positive signals in
glomerula. This stresses the differences between various species in
renal PrP
Sc deposition and may underline possible consequences
for enabling horizontal prion transmission in particular species. By
Figure 2. PET blot analysis identifying PrP
Sc in the tubular structures
of the cortex and medulla in naturally scrapie-sick Sarda sheep. (A)
Brains of scrapie-sick (left) and healthy sheep (right) as a control for PET
blot analysis procedure. Scale bar=100 mm. (B) Low magnification of
transverse paraffin sections from kidneys of a naturally scrapie-sick and
a healthy sheep demonstrating PrP
Sc in the medullary and cortical
regions of the kidney. Dotted lines indicate the locus of the kidney
capsule or the edge of the tissue section. The small transparent box
indicates the region shown at higher magnification and resolution in
figure C. Scale bar=1 cm. (C) PrP
Sc deposits and tubular structure fit
together in the cortical part of the kidney in scrapie-sick sheep. Scale
bar=100 mm. (D) PrP
Sc is also found to a high degree in the collecting
ducts of the medulla (arrowhead) as well as in the papillae (arrow) of
kidneys derived from naturally scrapie infected sheep. Scale
bar=30 mm.
doi:10.1371/journal.pone.0000859.g002
Figure 3. PrP
Sc detected by immunohistochemistry in scrapie-
affected Sarda sheep. (A) Immunohistochemical analysis of the cortex,
medulla and papillae of naturally scrapie-sick sheep and control sheep
derived from scrapie-free flocks. Antibodies 2G11 and F99 were used.
Scale bar=30 mm. (B) Immunofluorescence using 2G11 identifies
tubular deposits in the medullar-cortical junction of the kidney of
a scrapie-sick sheep. Scrapie-free control is devoid of detectable
positive signal.
doi:10.1371/journal.pone.0000859.g003
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presence of pathological prion protein, which they called PrP
d.
The authors found PrP
d only in the renal medulla of scrapie sick
sheep. By conventional and NaPTA-Western blot analysis we were
able to detect PrP
Sc in cortex and medulla in similar amounts,
whereas immunohistochemistry revealed stronger signals in
medulla than in the cortex. In this study, conventional and
NaPTA-Western blot analysis detected a comparable prevalence
of kidneys positive for PrP
Sc. The observation of cortical PrP
Sc
deposition as well as the higher incidence of PrP
Sc found in
Sardinian and Abruzzo flocks when compared to the publication
by Siso ´ et al. [30], might result from differences in the flock origin,
different scrapie strain or scrapie disease progression. In our study,
the sequencing of the PrP gene showed that sheep had the same
ARQ haplotype, indicating that the renal PrP
Sc deposition is not
due to polymorphic variations of the PrP gene. Since Siso ´e ta l
[30] found a higher presence of PrP
Sc in sheep experimentally
inoculated with an ARQ/ARQ Suffolk isolate, the deposition of
PrP
Sc might be mostly influenced by the source of the etiological
agent. Further studies are needed to establish whether renal PrP
Sc
deposition occurs in a similar manner in VRQ/VRQ sheep
naturally affected by scrapie.
Most importantly, our survey demonstrated that renal PrP
Sc
deposition is mostly relegate to the clinical stage of the disease,
indeed only 3 out of the 11 asymptomatic sheep harbored PrP
Sc in
the kidney. In addition the immunohistochemical patterns that
were observed in brain of these 3 sheep were indicative of clinical
scrapie, suggesting a later stage of the disease.
In contrast to the previously published studies, we conclusively
demonstrate for the first time, by using immunohistochemical,
immunofluorescent and PET blot analysis, intraepithelial, but not
glomerular, deposition of PrP
Sc in kidney. However, the deposition
patterns detected by immunohistochemistry vary with the epitope
specificity of the detecting antibody, indicative of different PrP
Sc
isoforms or differential processing in the kidney of naturally
scrapie-sick sheep. This finding is again in contrast to the
previously published study that indicated differences in staining
intensity but not in staining pattern [30]. In this case it is
reasonable to suppose that differences in immunohistochemical
procedures (e.g. formalin fixation, antibodies, etc.) can play an
important role.
Indeed, using the same antibodies (F99 and G11) Vascellari et
al. [10] found analogous PrP
Sc deposition patterns in the salivary
glands of ARQ/ARQ sheep with scrapie. This might suggest, on
one side, a similar mechanisms of PrP
Sc accumulation in the
kidney and in the salivary glands, on the other, a similar role of the
filtrating epithelial cells and of the secreting epithelial cells in
spreading prions.
Since prion infectivity was demonstrated in blood of sheep [21],
in the light of these results it could be hypothesized that blood
contains prions which could be filtered and accumulated by the
kidney, resulting in renal PrP
Sc accumulation. A multitude of
experimental paradigms shows that prion diseases can be trans-
mitted from one individual to another. Many of the parameters
controlling transmissibility are relatively well understood. Firstly
the size of the infectious inoculum, secondly the route, with
intracerebral inoculation being more efficient than oral, in-
traperitoneal and intravenous injection, thirdly the polymorphisms
in the Prnp gene of both donor and recipient.
For a living organism to initiate horizontal transmission under
field conditions of any infectious agent, including prions, the agent
must be released from the organism into the environment, through
respiratory aerosols, bodily secretions, or excrements. The
unsuccessful attempts at eradicating scrapie from Icelandic flocks
in the 20
th century bear witness to the likelihood of environmental
prion contamination. Additional pathways of horizontal trans-
mission of sheep scrapie may include parasitic vectors [31,32] and
placental cannibalism within flocks [9]. The importance of the two
latter routes in naturally occurring transmission of field cases,
however, is supported by limited evidence.
Previous studies in sheep, humans, and genetically modified
mice have pointed to inflammatory conditions as a cofactor
enabling prion replication in disparate tissues, including liver,
pancreas, skeletal muscle, mammary gland, and kidney [11,25,8].
The function of the latter organs is excretion, and indeed chronic
lymphofollicular nephritis leads to prionuria in prion-infected mice
[24]. As a first step towards investigating the relevance of prionuria
in horizontal transmission of scrapie, we undertook to investigate
the presence of PrP
Sc in sheep kidney.
Work in progress will define the spatiotemporal mechanisms of
renal PrP
Sc deposition in subclinical and naturally scrapie-sick
sheep as well as the epidemiological importance of this finding.
Due to prion infectivity detected in sheep blood, it is not surprising
that renal prion deposition can occur independent of lymphocytic
inflammatory disorders. Potentially, renal prion deposition could
be a result of blood borne prions. Prions were recently
demonstrated in blood of 50–60% of subclinical and in .80%
of terminal hamsters [17]. This could explain why also subclinical
sheep could accumulate prions in kidney but to less degree and
Figure 4. Quantification of PrP
Sc in renal homogenates of naturally
scrapie-sick sheep. (A) Conventional Western blot analysis of various
brain dilutions after proteinase K (PK) digestion. Undigested brain is
loaded to control for PK digest (lane 1). Kidney homogenates from
independent scrapie sick animals were loaded (lanes 7–10). (B) Relative
quantification of PrP
Sc signal intensity found in kidney homogenates in
relation to brain derived PrP
Sc. Our results indicate that the highest
amounts of renal PrP
Sc detected were appr. up to 20% of the PrP
Sc
signal detected in brain.
doi:10.1371/journal.pone.0000859.g004
PrPSc in Kidneys of Sheep
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renal cells that are capable of prion replication itself.
It will be extremely important to evaluate whether inflammation
can further increase renal deposition of PrP
Sc and whether prion
infectivity can be detected in kidney and urine of naturally scrapie-
sick sheep, during the clinical and preclinical stage. Our data
suggest that prionuria might indeed be possible in an unexpected
high percentage of affected animals, presenting an important co-
factor for horizontal prion transmission.
MATERIALS AND METHODS
Sampling
Our study was carried on experimentally and naturally infected
sheep as well as appropriate control sheep located in Sardinia and
Abruzzo (Italy). In Sardinia, we set out to investigate naturally
scrapie-sick Sarda sheep (n=72) from 14 distinct flocks as well as
experimentally scrapie-sick Sarda sheep (n=9), inoculated with
25 ml of a 10% brain homogenate (pooled from natural ARQ/
ARQ sheep scrapie cases) at 40 days of age. Additionally, to verify
whether our hypothesis was valid in different and geographically
separated breed we investigated an additional scrapie outbreak in
Abruzzo, where we analyzed Comisana-crossed breed sheep with
natural clinical scrapie (n=3), (Table 1).
All the sheep (n=75) coming from these different sources were
sacrificed at clinical stage of the disease. Lastly, to define whether
PrP
Sc deposition already occurs at asymptomatic stage of the
disease, we analyzed 11 asymptomatic scrapie-affected sheep from
a single flock located in Sardinia. In addition, 30 control Sarda
breed sheep from flocks without scrapie cases and 67 healthy sheep
from 2 scrapie affected flocks, located respectively in Abruzzo
(n=18 sheep) and in Sardinia (n=49 sheep) were analyzed, other
details are reported in Table 1.
All the 9 ARQ/ARQ orally infected sheep, after an average
incubation period of 650 days (+/225 days) showed clinical signs
of scrapie and were sacrificed at terminal stage (mean clinical
course=27 days). The 75 naturally scrapie-affected sheep with
clinical signs were monitored in the open field on a constant basis
and sacrificed at terminal stage, approximately 40 days after the
onset of the first clinical signs.
From all sheep we collected brain, palatine tonsil, kidney and
spleen, which were partly frozen at 220uCo r280uC and partly
fixed in 10% neutral buffered formalin. For investigating the
regional distribution of PrP
Sc in kidneys we separated cortex and
medulla by macro-dissecting transversal sections of whole kidneys
and used pooled (cortex and medulla) or separated regions for
Western blot analysis.
Conventional WB analysis
Frozen kidney, nervous and LRS tissue samples were thawed and
then submitted to an appropriate Western-blotting (WB) protocol
for PrP
Sc detection. For the examination of kidney, this was carried
out by means of a modified Prionics check protocol (Prionics AG,
Switzerland), with 1 g of kidney being first incubated in TBS buffer
(10 mM Tris HCl, 133 mM NaCl, pH 7.4) containing 1,5 mM
CaCl2 and 2.5 mg/ml (final concentration) of type XI collagenase
1.6 U/mg (Sigma, USA) for 2 h at 37uC. Samples were sub-
sequently centrifuged at 30 000 g for 2–30 min at 4uC, with the
pellets resuspended in the homogenization buffer (20% w/v) which
is included in the Prionics check kit (Prionics AG, Switzerland), and
homogenized using an automatic system (Fasth PCPM, Italy). A
5000 ml volume of this homogenate was incubated with 500 mlo f
106digestion buffer and proteinase K (50 mg/ml), both of which
werealso included in the Prionics check kit, at 50uC for 40 min, and
the reaction was blocked with 50 ml of digestion stop buffer. After
digestion, further concentration steps were performed by centrifu-
gation at 30,000 g for 30 min at 4uC. Pellets were resuspended in
20 mlo f1 6NuPage SDS reducing bufferand 10 ml of eachsolution
was loaded on (12%) NuPAGE Novex Bis-Tris Gels 12 wells
(Invitrogen, USA) for electrophoresis under constant application of
120 V for 45 min. Electroblotting was performed onto polyvinyli-
dene fluoride membranes (150 V for 1 h). For PrP
Sc detection,
membranes were incubated over night at 4uC with P4 monoclonal
antibody (MoAb) (1:15,000), which is specific for the aa89-104 of
the ovine PrP [33]. After washing with a solution of 10 mM Tris
HCl, 133 mM NaCl, and 0.2% Tween 20 (TBST), the secondary
Abdiluted1:5000 wasaddedtothereaction,with membranesbeing
subsequently washed 4 times for 5 min, equilibrated in lumines-
cence buffer, placed in chemiluminescent substrate (Roche,
Switzerland), and finally exposed to an X-Ray film. Examination
of the obex was carried out using the Prionics check kit, in
accordance with the manufacturer’s instructions.
Western blot analysis with Sodium
phosphotungstate (NaPTA) precipitation
10% homogenates of brain and kidney were prepared in 2%
Sarcosyl or PBS. Gross cellular debris were removed by
centrifugation at 500 g for 1 min. The resulting supernatant was
adjusted to 500 ml with PBS, and mixed 1:1 with 4% Sarkosyl in
PBS. Samples were incubated for 15 min at 37uC under constant
agitation. Benzonase and MgCl2 were added to a final concen-
tration of 50 U/ml and 12.75 mM respectively, and incubated for
30 min at 37uC under continuous agitation. Pre-warmed PTA
stock solution (pH 7.4) was added to a final concentration of 0.3%
and the sample was incubated at 37uC for 30 min with constant
agitation, followed by centrifugation at 37uC for 30 min at
maximum speed (14800 g) in an Eppendorf microcentrifuge. The
pellet was resuspended in 30 ml 0.1% Sarkosyl in PBS and digested
with 30 or 50 mg/ml proteinase K (PK) for 30 min at 37uC with
agitation. The sample was heated at 95uC for 5 min in SDS-
containing loading buffer before loading onto 10,12 or 16% Novex
SDS polyacrylamide gels (Invitrogen, USA), then wet-blotting
were performed as described in the previous paragraph using as
primary antibody POM1/POM19 or POM19 alone, which bind
on distinct epitopes on the globular domain of PrP [34].
Quantification of total brain or kidney protein
From 10% homogenates of kidney and brain was performed with
a BCA
TM Protein Assay Kit, according to the manufacturer `s
protocol (23-225 BCA
TM Protein Assay Kit, Pierce).
Quantification of PrP
Sc in brain and kidney
To analyze and to quantify PrP
Sc in ovine kidney homogenates of
natural scrapie sick sheep 250–400 mg total protein of selected
kidney samples were digested with proteinase K (50 mg/ml) for
30 min at 37uC and loaded on a pre-casted 12%-SDS gel
(NuPAGE). Proteins were transferred to nitrocellulose (Schleicher-
Schuell, Germany) by wet-blotting. Membranes were blocked with
TBST containing 5% Top Block or 5% bovine serum albumine
(BSA) (Juro, Switzerland). As primary MoAb was applied P4 and
also POM1 and/or POM19. On the same blot serial dilutions of
brain homogenate (2–0.125 mg), spiked into 300 mg kidney protein
derived from a sheep without clinical signs, were PK digested,
loaded and developed. To control PK digest, undigested and
digested brain homogenate as well as a dual color marker were
loaded. Blots were developed until the three characteristic, shifted,
PK resistant bands appeared in the kidney homogenates. Signals
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saturated, linear range after development using the VersaDoc
imaging system (Biorad) and Quantity oneH software (Biorad).
Thereby a standard curve was generated, allowing relative
quantification of PrP
Sc/mg of brain or kidney tissue.
Immunohistochemical techniques
Tissues were formalin-fixed, treated for 1 hr in 98% formic acid,
and embedded in paraffin using conventional protocol. For
histopathology, nervous and renal specimens were cut into 5 mm-
thick sections and stained by haematoxylin and eosin (HE) and then
examined by light microscope examination. For immunofluores-
cence, tissue sections, mounted onto positively charged glass slides,
were autoclaved in a citrate buffer (pH 6.1) at 121uC for 10 min to
expose epitopes. Slides were immersed in a solution of 0.3% H2O2
for 10 min at room temperature (RT) to quench endogenous
peroxidase activity, rinsed with PBS and nonspecific sites were
blocked in 5% BSA in PBS. Slides were then incubated with anti-
PrP monoclonal antibody 2G11 followed by an incubation with an
Alexa Fluor conjugate 594 secondary antibody. Negative tissue
controls included kidneys from ARR/ARR scrapie-negative sheep.
Forimmunohistochemistry, tissue sectionswerefirst driedovernight
at 37uC, rehydrated and then autoclaved at 121uC for 10 min in
a solution of 0.01 M citric acid (pH 6.1). Further steps included
utilization of a biotin-streptavidin detection method (Vector
Laboratories, Inc., U.S.A.), using the following primary monoclonal
antibodies (MoAbs): 2G11 (1 mg/ml) (1: 500) and (1 mg/ml) F99
(1:800). 2G11 and F99 antibodies have epitopes on aa151-159 and
aa220-225 of the ovine PrP, respectively. Immune reactions were
visualized by 3-39-diaminobenzidine (DAB) chromogen solution
(Dako, Denmark). Tissue sections from ARR/ARR scrapie-
negative sheep were included in each run as control. Another series
of controls was set up by omitting the primary MoAbs.
Paraffin-embedded tissue (PET) blot analysis
2 mm thick paraffin sections were collected on a nitrocellulose-
membrane and dried over night at 37uC and just before use for 1h
at 56uC. Deparaffinization in Xylol, twice for 5 min, followed by
100% isopropanol, twice for 2 min, 95% isopropanol, once for
2 min and 70% isopropanol (once for 2 min). The membranes
were then washed in 0.1% Tween-20 in distilled water for 10 min
and air-dried over night. This procedure was followed by
a washing step in 16 Tris-buffered Saline with 0.5% Tween-20
(TBST) for 1 hr and a PK digestion (Roche) (250 mg Proteinase
K/ml) in digestion buffer (100 mM NaCl, 0.1% Brij 35 in 10mM
Tris-HCl, pH 7.8) at 55uC for 8 hrs. PK digestion was followed by
washing steps in TBST (3610 min). Denaturation 3M Guanidi-
nium thiocyatnate (Sigma) in 10 mM Tris-HCl, pH 7.8) for
10 min was followed by further washing steps in 16 TBST
(3610 min) and blocking with 5% low fat milk in 16 TBST
(blocking buffer), for 1 hr. Thereafter the primary MoAb POM1
or 2G11 (POM1: 200 ng/ml; 2G11: 500 ng/ml) in 1% low fat
milk in 16TBST was incubated over night at RT. Washing was
performed thereafter in 16 TBST (3610 min) followed by
blocking in 1% low fat milk 16 TBST for 5 min. Incubation of
the secondary secondary AB (Vector or DAKO D0486, AP-
conjugated goat anti mouse; 1:1000) was performed with the
membrane for 2 hrs–3 hrs at RT., followed by washing with 5%
low fat milk in 1 6 (3610 min). For development of signal
Vecstain ABC–AmP (Vector) was incubated for 10 min at RT
followed by incubation with BCP/NBT for 30 min at RT. After
a final washing step in 5% low fat milk in 16TBST the blots were
air dried and flattened with a glass plate for visual inspection.
Alternatively, for development of signal B3 DIG was incubated for
10 min followed by incubation with NBT and BCIP for 1 hr. After
a final washing step in distilled water for at least 30 min the blots
were air-dried and flattened with a glass plate for visual inspection.
As positive and negative controls the brain of terminal scrapie-sick
sheep and ARR/ARR sheep were used, respectively.
Genetic analysis
The PrP genotypes of all investigated sheep were determined
focusing on the PrP gene (PRNP) polymorphisms at codons 136,
154, and 171, keeping in mind that the polymorphic site which is
known to influence susceptibility/resistance to scrapie in Sarda
breed sheep is represented by codon 171, with 171 Q/Q
homozygous sheep being the most susceptible to disease. DNA
was isolated from EDTA-treated blood and submitted to
appropriate TaqMan allelic discrimination using ABI Prism
(Applied Biosystem, USA), as described elsewhere [35]. Addition-
ally, from 16 scrapie affected sheep, of which only 8 with PrP
Sc in
the kidney, genomic DNA was isolated from the brain tissue by the
DNA isolation kit (Qiagen, USA). PCR amplification of the PrP
gene was performed using the following primers: PrP1(+), 59-
ATGGTGAAAAGCCACATAGGCAGT-39, and PrP2(2), 59-
CTATCCTACTATGAGAAAAATGAG-39. The PrP1(+) and
PrP2(2) anneal at the extreme 59 and 39 regions of the PrP-
coding sequence, respectively. Amplification reactions were
performed for 30 cycles of 30 sec at 94uC, 30 sec at 59uC, and
45 sec at 72uC. PrP gene polymorphisms were detected by DNA
sequencing on both strands of the PCR products (Applied
Biosystems, USA).
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